TrialThe lancet. HIV2023

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial.

Rulan Griesel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.